Paper42007189
Guideline-Directed Medical Therapy in Patients After Implantation of Implantable Cardioverter Defibrillators to Improve Outcomes.
Parkash R and 5 others. CJC Open, 2026. Cited by 0 papers, by iCite.
Cite this record
ConductScience Library. Guideline-Directed Medical Therapy in Patients After Implantation of Implantable Cardioverter Defibrillators to Improve Outcomes. Papers, record 42007189. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/42007189
- Sources
- 11 sources
- Release
- papers-2026-11-12-0.1.0
Paper
PubMed's record of the paper, with iCite's citation figures. No abstract is shown.
- Title
- Guideline-Directed Medical Therapy in Patients After Implantation of Implantable Cardioverter Defibrillators to Improve Outcomes.
- PubMed
Topics0
NLM's MeSH indexing of the paper, its major topics first.
None in this release.
References21
The papers the reference list in PubMed's record names, those in our copy of PubMed, in the list's order.
| Order | PMID | Title | Journal | Year | In Papers | Source |
|---|---|---|---|---|---|---|
| 1 | 19746249 | Heart failure clinics are associated with clinical benefit in both tertiary and community care settings: data from the Improving Cardiovascular Outcomes in Nova Scotia (ICONS) registry. | Can J Cardiol | 2009 | https://conductscience.org/library/papers/19746249 | PubMed |
| 2 | 29997002 | Shortening of paced QRS duration after electrocardiographic optimization of left ventricular pacing vector in patients treated with Cardiac Resynchronization Therapy. | J Electrocardiol | 2018 | https://conductscience.org/library/papers/29997002 | PubMed |
| 3 | 27206819 | 2016 ESC Guidelines for the diagnosis and treatment of acute and chronic heart failure: The Task Force for the diagnosis and treatment of acute and chronic heart failure of the European Society of Cardiology (ESC)Developed with the special contribution of the Heart Failure Association (HFA) of the ESC. | Eur Heart J | 2016 | https://conductscience.org/library/papers/27206819 | PubMed |
| 4 | 26940927 | Use of Guideline-Directed Medications for Heart Failure Before Cardioverter-Defibrillator Implantation. | J Am Coll Cardiol | 2016 | https://conductscience.org/library/papers/26940927 | PubMed |
| 5 | 21550578 | Importance of adjunctive heart failure optimization immediately after implantation to improve long-term outcomes with cardiac resynchronization therapy. | Am J Cardiol | 2011 | https://conductscience.org/library/papers/21550578 | PubMed |
| 6 | 39921334 | SGLT2i reduce arrhythmic events in heart failure patients with cardiac implantable electronic devices. | ESC Heart Fail | 2025 | https://conductscience.org/library/papers/39921334 | PubMed |
| 7 | 28461007 | 2017 ACC/AHA/HFSA Focused Update of the 2013 ACCF/AHA Guideline for the Management of Heart Failure: A Report of the American College of Cardiology/American Heart Association Task Force on Clinical Practice Guidelines and the Heart Failure Society of America. | J Am Coll Cardiol | 2017 | https://conductscience.org/library/papers/28461007 | PubMed |
| 8 | 38560378 | Outcomes with guideline-directed medical therapy and cardiac implantable electronic device therapies for patients with heart failure with reduced ejection fraction. | Heart Rhythm O2 | 2024 | https://conductscience.org/library/papers/38560378 | PubMed |
| 9 | 29402420 | Effect of Optimization of Medical Treatment on Long-Term Survival of Patients With Heart Failure After Implantable Cardioverter Defibrillator and Cardiac Resynchronization Device Implantation (from the French National EGB Database). | Am J Cardiol | 2018 | https://conductscience.org/library/papers/29402420 | PubMed |
| 10 | 24237881 | Fusion-optimized intervals (FOI): a new method to achieve the narrowest QRS for optimization of the AV and VV intervals in patients undergoing cardiac resynchronization therapy. | J Cardiovasc Electrophysiol | 2014 | https://conductscience.org/library/papers/24237881 | PubMed |
| 11 | 20197509 | Underutilization of beta-blockers in patients undergoing implantable cardioverter-defibrillator and cardiac resynchronization procedures. | Circ Cardiovasc Qual Outcomes | 2010 | https://conductscience.org/library/papers/20197509 | PubMed |
| 12 | 33827756 | CCS/CHFS Heart Failure Guidelines Update: Defining a New Pharmacologic Standard of Care for Heart Failure With Reduced Ejection Fraction. | Can J Cardiol | 2021 | https://conductscience.org/library/papers/33827756 | PubMed |
| 13 | 39393749 | Delta QRS and outcomes post CRT in the Resynchronization-Defibrillation for Ambulatory Heart Failure Trial. | Heart Rhythm | 2025 | https://conductscience.org/library/papers/39393749 | PubMed |
| 14 | 35981790 | Guideline-Directed Medical Therapy and the Risk of Death in Primary Prevention Defibrillator Recipients. | JACC Clin Electrophysiol | 2022 | https://conductscience.org/library/papers/35981790 | PubMed |
| 15 | 29111106 | 2017 Comprehensive Update of the Canadian Cardiovascular Society Guidelines for the Management of Heart Failure. | Can J Cardiol | 2017 | https://conductscience.org/library/papers/29111106 | PubMed |
| 16 | 37208301 | 2023 HRS/EHRA/APHRS/LAHRS Expert Consensus Statement on Practical Management of the Remote Device Clinic. | Europace | 2023 | https://conductscience.org/library/papers/37208301 | PubMed |
| 17 | 39551747 | Impact of implantable cardioverter defibrillators on mortality in heart failure receiving quadruple guideline-directed medical therapy: a propensity score-matched study. | BMC Med | 2024 | https://conductscience.org/library/papers/39551747 | PubMed |
| 18 | 31535829 | Dapagliflozin in Patients with Heart Failure and Reduced Ejection Fraction. | N Engl J Med | 2019 | https://conductscience.org/library/papers/31535829 | PubMed |
| 19 | 23351926 | Canadian Cardiovascular Society guidelines on the use of cardiac resynchronization therapy: evidence and patient selection. | Can J Cardiol | 2013 | https://conductscience.org/library/papers/23351926 | PubMed |
| 20 | 28034580 | Canadian Cardiovascular Society/Canadian Heart Rhythm Society 2016 Implantable Cardioverter-Defibrillator Guidelines. | Can J Cardiol | 2017 | https://conductscience.org/library/papers/28034580 | PubMed |
Data dates
The date of each source this release read.
- Trials
- 2026-11-12
- Gene search
- 2026-11-11
- Pipelines
- 2026-09-18
None in this release
- Grants
- Trials
- Comments and corrections
- Cited by
- Genes
- Drugs
- Data
Sources 11
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- HGNCCC0
- iCiteCC BY 4.0
- NCBI GenePublic domain (US government)
- NIH RePORTER's grant and paper linksPublic domain
- Open TargetsCC0 1.0
- PMC's ID filePublic domain (US government)
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- HGNCCC0: https://www.genenames.org/about/license/
- iCiteCC BY 4.0
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this paper from software.
The record and each of its lists are JSON, twenty rows a page. No key.
GET https://conductscience.org/api/papers/v1/42007189
GET https://conductscience.org/api/papers/v1/42007189/references?page=2